Literature DB >> 21976654

Modeling of human cytomegalovirus maternal-fetal transmission in a novel decidual organ culture.

Yiska Weisblum1, Amos Panet, Zichria Zakay-Rones, Ronit Haimov-Kochman, Debra Goldman-Wohl, Ilana Ariel, Haya Falk, Shira Natanson-Yaron, Miri D Goldberg, Ronit Gilad, Nell S Lurain, Caryn Greenfield, Simcha Yagel, Dana G Wolf.   

Abstract

Human cytomegalovirus (HCMV) is the leading cause of congenital infection, associated with severe birth defects and intrauterine growth retardation. The mechanism of HCMV transmission via the maternal-fetal interface is largely unknown, and there are no animal models for HCMV. The initial stages of infection are believed to occur in the maternal decidua. Here we employed a novel decidual organ culture, using both clinically derived and laboratory-derived viral strains, for the ex vivo modeling of HCMV transmission in the maternal-fetal interface. Viral spread in the tissue was demonstrated by the progression of infected-cell foci, with a 1.3- to 2-log increase in HCMV DNA and RNA levels between days 2 and 9 postinfection, the expression of immediate-early and late proteins, the appearance of typical histopathological features of natural infection, and dose-dependent inhibition of infection by ganciclovir and acyclovir. HCMV infected a wide range of cells in the decidua, including invasive cytotrophoblasts, macrophages, and endothelial, decidual, and dendritic cells. Cell-to-cell viral spread was revealed by focal extension of infected-cell clusters, inability to recover infectious extracellular virus, and high relative proportions (88 to 93%) of cell-associated viral DNA. Intriguingly, neutralizing HCMV hyperimmune globulins exhibited inhibitory activity against viral spread in the decidua even when added at 24 h postinfection-providing a mechanistic basis for their clinical use in prenatal prevention. The ex vivo-infected decidual cultures offer unique insight into patterns of viral tropism and spread, defining initial stages of congenital HCMV transmission, and can facilitate evaluation of the effects of new antiviral interventions within the maternal-fetal interface milieu.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21976654      PMCID: PMC3233115          DOI: 10.1128/JVI.05749-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  76 in total

Review 1.  Insights into viral transmission at the uterine-placental interface.

Authors:  Lenore Pereira; Ekaterina Maidji; Susan McDonagh; Takako Tabata
Journal:  Trends Microbiol       Date:  2005-04       Impact factor: 17.079

2.  Characterization of human cytomegalovirus glycoprotein-induced cell-cell fusion.

Authors:  Eric R Kinzler; Teresa Compton
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

3.  Human trophoblast cells are permissive to the complete replicative cycle of human cytomegalovirus.

Authors:  G Halwachs-Baumann; M Wilders-Truschnig; G Desoye; T Hahn; L Kiesel; K Klingel; P Rieger; G Jahn; C Sinzger
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

Review 4.  Congenital cytomegalovirus infection and disease.

Authors:  G J Demmler
Journal:  Adv Pediatr Infect Dis       Date:  1996

5.  Permissive cytomegalovirus infection of primary villous term and first trimester trophoblasts.

Authors:  D G Hemmings; R Kilani; C Nykiforuk; J Preiksaitis; L J Guilbert
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

6.  Dendritic-cell infection by human cytomegalovirus is restricted to strains carrying functional UL131-128 genes and mediates efficient viral antigen presentation to CD8+ T cells.

Authors:  Giuseppe Gerna; Elena Percivalle; Daniele Lilleri; Laura Lozza; Chiara Fornara; Gabriele Hahn; Fausto Baldanti; M Grazia Revello
Journal:  J Gen Virol       Date:  2005-02       Impact factor: 3.891

Review 7.  Congenital cytomegalovirus infection: outcome and diagnosis.

Authors:  Shannon A Ross; Suresh B Boppana
Journal:  Semin Pediatr Infect Dis       Date:  2005-01

8.  Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus.

Authors:  Tal I Arnon; Hagit Achdout; Ofer Levi; Gal Markel; Nivin Saleh; Gil Katz; Roi Gazit; Tsufit Gonen-Gross; Jacob Hanna; Efrat Nahari; Angel Porgador; Alik Honigman; Bodo Plachter; Dror Mevorach; Dana G Wolf; Ofer Mandelboim
Journal:  Nat Immunol       Date:  2005-04-10       Impact factor: 25.606

9.  Developmental regulation of human cytomegalovirus receptors in cytotrophoblasts correlates with distinct replication sites in the placenta.

Authors:  Ekaterina Maidji; Olga Genbacev; Hsin-Ti Chang; Lenore Pereira
Journal:  J Virol       Date:  2007-02-21       Impact factor: 5.103

10.  HCMV spread and cell tropism are determined by distinct virus populations.

Authors:  Laura Scrivano; Christian Sinzger; Hans Nitschko; Ulrich H Koszinowski; Barbara Adler
Journal:  PLoS Pathog       Date:  2011-01-13       Impact factor: 6.823

View more
  44 in total

Review 1.  Current concepts in maternal-fetal immunology: Recognition and response to microbial pathogens by decidual stromal cells.

Authors:  Anjali P Anders; Jennifer A Gaddy; Ryan S Doster; David M Aronoff
Journal:  Am J Reprod Immunol       Date:  2017-01-03       Impact factor: 3.886

Review 2.  Intrauterine therapy of cytomegalovirus infection with valganciclovir: review of the literature.

Authors:  Vera Seidel; Cornelia Feiterna-Sperling; Jan-Peter Siedentopf; Jörg Hofmann; Wolfgang Henrich; Christoph Bührer; Katharina Weizsäcker
Journal:  Med Microbiol Immunol       Date:  2017-07-21       Impact factor: 3.402

Review 3.  Manipulation of host pathways by human cytomegalovirus: insights from genome-wide studies.

Authors:  Yifat Cohen; Noam Stern-Ginossar
Journal:  Semin Immunopathol       Date:  2014-09-27       Impact factor: 9.623

4.  APOBEC3A Is Upregulated by Human Cytomegalovirus (HCMV) in the Maternal-Fetal Interface, Acting as an Innate Anti-HCMV Effector.

Authors:  Yiska Weisblum; Esther Oiknine-Djian; Zichria Zakay-Rones; Olesya Vorontsov; Ronit Haimov-Kochman; Yuval Nevo; David Stockheim; Simcha Yagel; Amos Panet; Dana G Wolf
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

5.  Limited Colonization Undermined by Inadequate Early Immune Responses Defines the Dynamics of Decidual Listeriosis.

Authors:  Gabrielle Rizzuto; Elisa Tagliani; Priyanka Manandhar; Adrian Erlebacher; Anna I Bakardjiev
Journal:  Infect Immun       Date:  2017-07-19       Impact factor: 3.441

6.  Transition toward Human Cytomegalovirus Susceptibility in Early Human Embryonic Stem Cell-Derived Neural Precursors.

Authors:  Amnon A Berger; Yaniv Gil; Amos Panet; Yiska Weisblum; Esther Oiknine-Djian; Michal Gropp; Debora Steiner; Benjamin E Reubinoff; Dana G Wolf
Journal:  J Virol       Date:  2015-08-19       Impact factor: 5.103

7.  Zika Virus Infects Early- and Midgestation Human Maternal Decidual Tissues, Inducing Distinct Innate Tissue Responses in the Maternal-Fetal Interface.

Authors:  Yiska Weisblum; Esther Oiknine-Djian; Olesya M Vorontsov; Ronit Haimov-Kochman; Zichria Zakay-Rones; Karen Meir; David Shveiky; Sharona Elgavish; Yuval Nevo; Moshe Roseman; Michal Bronstein; David Stockheim; Ido From; Iris Eisenberg; Aya A Lewkowicz; Simcha Yagel; Amos Panet; Dana G Wolf
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

8.  Human cytomegalovirus infection interferes with the maintenance and differentiation of trophoblast progenitor cells of the human placenta.

Authors:  Takako Tabata; Matthew Petitt; Martin Zydek; June Fang-Hoover; Nicholas Larocque; Mitsuru Tsuge; Matthew Gormley; Lawrence M Kauvar; Lenore Pereira
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

Review 9.  Microbial Vertical Transmission during Human Pregnancy.

Authors:  Nitin Arora; Yoel Sadovsky; Terence S Dermody; Carolyn B Coyne
Journal:  Cell Host Microbe       Date:  2017-05-10       Impact factor: 21.023

Review 10.  The "silent" global burden of congenital cytomegalovirus.

Authors:  Sheetal Manicklal; Vincent C Emery; Tiziana Lazzarotto; Suresh B Boppana; Ravindra K Gupta
Journal:  Clin Microbiol Rev       Date:  2013-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.